1. Home
  2. GHRS vs ASPN Comparison

GHRS vs ASPN Comparison

Compare GHRS & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • ASPN
  • Stock Information
  • Founded
  • GHRS 2018
  • ASPN 2001
  • Country
  • GHRS Ireland
  • ASPN United States
  • Employees
  • GHRS N/A
  • ASPN N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • ASPN RETAIL: Building Materials
  • Sector
  • GHRS Health Care
  • ASPN Consumer Discretionary
  • Exchange
  • GHRS Nasdaq
  • ASPN Nasdaq
  • Market Cap
  • GHRS 583.1M
  • ASPN 570.6M
  • IPO Year
  • GHRS 2021
  • ASPN 2014
  • Fundamental
  • Price
  • GHRS $10.60
  • ASPN $4.86
  • Analyst Decision
  • GHRS Strong Buy
  • ASPN Strong Buy
  • Analyst Count
  • GHRS 8
  • ASPN 10
  • Target Price
  • GHRS $30.63
  • ASPN $22.44
  • AVG Volume (30 Days)
  • GHRS 146.4K
  • ASPN 1.9M
  • Earning Date
  • GHRS 05-08-2025
  • ASPN 05-08-2025
  • Dividend Yield
  • GHRS N/A
  • ASPN N/A
  • EPS Growth
  • GHRS N/A
  • ASPN N/A
  • EPS
  • GHRS N/A
  • ASPN N/A
  • Revenue
  • GHRS N/A
  • ASPN $436,921,000.00
  • Revenue This Year
  • GHRS N/A
  • ASPN N/A
  • Revenue Next Year
  • GHRS N/A
  • ASPN $35.45
  • P/E Ratio
  • GHRS N/A
  • ASPN N/A
  • Revenue Growth
  • GHRS N/A
  • ASPN 51.90
  • 52 Week Low
  • GHRS $6.00
  • ASPN $4.16
  • 52 Week High
  • GHRS $20.50
  • ASPN $33.15
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 59.36
  • ASPN 32.84
  • Support Level
  • GHRS $9.81
  • ASPN $4.16
  • Resistance Level
  • GHRS $11.50
  • ASPN $5.73
  • Average True Range (ATR)
  • GHRS 0.72
  • ASPN 0.29
  • MACD
  • GHRS 0.23
  • ASPN -0.00
  • Stochastic Oscillator
  • GHRS 89.60
  • ASPN 17.60

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

Share on Social Networks: